ADHD and Anxiety: Which Came First?

You cannot tell whether you are anxious because you have anxiety, or anxious because you have ADHD and your life contains a reasonable amount to be anxious about. Your therapist treats the anxiety. The SSRIs take the edge off the dread, the CBT helps you challenge the catastrophic thoughts, and you feel somewhat better, for a while, in a way that never quite reaches the thing underneath. The problems that generate the anxiety, the missed deadlines, the forgotten appointments, the sense that you are always one mistake away from everything collapsing, continue. You are calmer about the chaos. The chaos persists.

The question of which came first is not academic. It determines what will actually help. And for roughly half of adults with ADHD, it is a question that needs answering.

How often they co-occur

The numbers are striking. Kessler and colleagues’ analysis of the National Comorbidity Survey Replication found that approximately 47% of adults with ADHD met criteria for an anxiety disorder [1]. This is not a small overlap. Nearly half of adults with ADHD are also managing clinically significant anxiety, which means that the experience of having ADHD without anxiety is actually the minority experience.

The most common comorbid anxiety conditions are generalized anxiety disorder (GAD) and social anxiety disorder [5]. GAD, with its persistent worry and difficulty controlling worry, overlaps symptomatically with the cognitive restlessness of ADHD. The person with GAD cannot stop worrying. The person with ADHD cannot stop their mind from moving. From the outside, and often from the inside, these feel the same: a brain that will not settle. Social anxiety, with its fear of negative evaluation, overlaps with the rejection sensitivity common in ADHD. The person with social anxiety fears being judged. The person with ADHD has been judged, repeatedly, for failures they could not prevent, and the anticipation of the next one produces a state that looks identical to social anxiety even though its origin is different.

The overlap is high enough that clinicians working with either condition should be screening for the other. In practice, this does not always happen. ADHD clinicians may attribute anxiety symptoms to the ADHD. Anxiety clinicians may not screen for ADHD at all, particularly in women whose presentation is predominantly inattentive.

The direction of causation

Schatz and Rostain describe three possible relationships between ADHD and anxiety [2]:

ADHD generates anxiety. Years of executive dysfunction produce a track record of missed deadlines, forgotten obligations, social missteps, and unpredictable performance. The anxiety is a rational response to a genuinely unpredictable situation: you do not know whether your brain will cooperate today, and the consequences of it not cooperating are real. This is secondary anxiety, produced by the ADHD, not independent of it.

The mechanism is straightforward. You have been late to enough things, forgotten enough things, failed to follow through on enough things, that your nervous system has learned to expect failure. The anxiety is not disordered. It is an accurate prediction based on a long history. You are anxious about the deadline because you have missed deadlines before, and you have missed deadlines before because your executive function could not sustain the work required to meet them. The anxiety is downstream of the ADHD, and treating the anxiety without treating the ADHD is treating the alarm while the fire continues.

Anxiety exists independently alongside ADHD. Both are common conditions, and their co-occurrence may reflect independent genetic and environmental risk factors. In this case, the anxiety has its own trajectory, its own triggers, and its own response to treatment. The person would have developed an anxiety disorder whether or not they had ADHD, and the two conditions interact without one being the cause of the other. Faraone and colleagues note that the genetic architectures of ADHD and anxiety disorders show some overlap but are largely distinct [4], which supports the possibility of genuine comorbidity rather than one condition always producing the other.

Anxiety mimics or masks ADHD. Anxiety can impair concentration, disrupt working memory, and make task initiation difficult, all of which look like ADHD. In some cases, what appears to be ADHD is actually anxiety-driven cognitive impairment. In other cases, the anxiety is being treated while the underlying ADHD goes unrecognized. A person treated for anxiety alone, whose concentration problems are attributed to the anxiety, may spend years on SSRIs and in therapy without anyone asking whether the concentration difficulty existed before the anxiety did, and whether it persists on days when the anxiety is well controlled.

In clinical practice, these categories often overlap. A person can have ADHD that generates anxiety, while also having a genetic predisposition to anxiety that exists independently. The secondary anxiety can compound the primary anxiety, and the combined load can make both conditions more severe than either would be alone. Sorting this out matters because the treatment approach differs, and getting it wrong means treating one condition while the other continues to drive the symptoms.

Concentration problems: ADHD or anxiety?

Both ADHD and anxiety impair concentration, but the mechanism is different, and the difference is clinically important.

In ADHD, concentration difficulty is a default state. The brain does not generate enough signal to sustain attention on tasks that are not inherently engaging. The difficulty is bottom-up: insufficient drive to maintain focus. You sit down to read the report. Your eyes move across the words. Nothing sticks, not because you are worried about something, but because the reading does not generate enough signal to hold your attention. The mind wanders, not to a specific worry, but to whatever offers more stimulation: a sound in the next room, a stray thought, the texture of the desk.

In anxiety, concentration difficulty comes from preoccupation. The mind is focused, but on the wrong thing: the worry, the feared outcome, the anticipated problem. The difficulty is top-down: attention is captured by the anxious content. You sit down to read the report and find yourself rehearsing the conversation you need to have with your manager, calculating how many days until the rent is due, running through the thing you said at lunch that might have been taken the wrong way. Your attention is not wandering. It is locked onto threat.

The practical difference: a person with ADHD-driven concentration problems often cannot say what they were thinking about instead of the task. They were not thinking about anything in particular. Their mind was somewhere, but nowhere specific. A person with anxiety-driven concentration problems can usually identify the worry that took over. They know exactly what displaced the report: it was the email from the school, or the test result they are waiting for, or the noise the car made this morning.

This distinction is not always clean. When ADHD and anxiety co-occur, the person may experience both: a wandering mind on low-anxiety days and a worry-captured mind on high-anxiety days, or some shifting combination throughout the same afternoon. But asking the question, “when you lose focus, can you identify what took your attention?” provides useful clinical information about which mechanism is dominant.

Treatment implications

The European Consensus Statement recommends that when ADHD and anxiety co-occur, clinicians should assess which condition is more impairing and treat it first [3]. This is a sequencing question, not an either-or question. Most adults with both conditions will eventually need treatment for both.

If anxiety is secondary to ADHD, treating the ADHD often reduces the anxiety. When the executive dysfunction improves, the situations generating anxiety, missed deadlines, forgotten commitments, social unpredictability, become less frequent. The anxiety reduces because the cause reduces. For these patients, stimulant medication may improve rather than worsen anxiety, despite the surface-level concern about giving a stimulant to an anxious person. The logic is counterintuitive but consistent: if the anxiety is produced by chaos, and the medication reduces the chaos, the anxiety has less to feed on.

If anxiety is primary and severe, it may need to be stabilized before ADHD treatment is effective. Severe anxiety can interfere with the ability to implement ADHD strategies, attend appointments consistently, or tolerate the trial-and-error of medication adjustment. A person in acute anxiety may not be able to sit through the weeks-long process of titrating a stimulant, or may interpret every side effect as evidence of catastrophe. Stabilizing the anxiety first, with SSRIs, CBT, or both, creates the conditions under which ADHD treatment can proceed.

Combined treatment. For many adults, the optimal approach is combined: ADHD medication to address the executive dysfunction, alongside CBT adapted for the anxiety. The CBT work addresses the thought patterns and avoidance behaviors that anxiety has built up over years; the medication addresses the underlying dysfunction that feeds them [4]. The combination works because each intervention addresses a different layer: the medication makes the executive system more functional, and the therapy addresses the psychological habits that formed during the years when it was not.

The stimulant question

A common concern is that stimulant medication will worsen anxiety. For some individuals, this is true, particularly at higher doses or with medications that produce a noticeable onset and offset. The physiological effects of stimulants, increased heart rate, heightened arousal, can be misinterpreted by an anxious brain as anxiety symptoms, creating a feedback loop that makes the anxiety worse.

But the clinical picture is more nuanced than “stimulants plus anxiety equals bad.” Many adults with ADHD and secondary anxiety find that stimulants reduce their anxiety by making the world more manageable. When you can follow through on your commitments, remember your appointments, and complete your work before the deadline, the anticipatory dread that accompanies every obligation has less material to work with. The dose and medication choice matter: lower starting doses, extended-release formulations that avoid sharp onset peaks, and non-stimulant options for those who are sensitive. Monitoring during the titration period is important, because the interaction between stimulants and anxiety is individual and cannot be predicted in advance.

The worst outcome is avoiding stimulant treatment entirely because of the anxiety, when the anxiety is being generated by the untreated ADHD. That decision protects against a risk (stimulant-worsened anxiety) while guaranteeing the continuation of the problem (ADHD-generated anxiety). It is a calculation that deserves more nuance than a blanket rule.

Where the evidence is thin

The treatment literature for ADHD with comorbid anxiety is smaller than the treatment literature for either condition alone. Most ADHD medication trials exclude participants with severe comorbid anxiety, which means the evidence base is weakest precisely where clinical complexity is highest. We need more trials that include, rather than exclude, the comorbid population, because the comorbid population is nearly half of adults with ADHD.

We also lack good comparative data on treatment sequencing. The recommendation to treat the more impairing condition first is reasonable but largely based on clinical experience rather than head-to-head trials. We do not know, from controlled data, whether treating ADHD first produces better long-term outcomes than treating anxiety first in the population that has both. The clinical consensus is informed by pattern recognition, not by the kind of evidence this site prefers to cite. That gap matters, and until it is closed, treatment decisions for the comorbid population will continue to rely more on clinical judgment than on data.

Getting a diagnosis or reviewing your options. If executive dysfunction is significantly affecting your work or daily life, speaking with a doctor about an ADHD assessment may be worthwhile. In the US, CHADD (chadd.org) has resources for adults seeking a diagnosis, including a provider directory. In the UK, the ADHD Foundation and AADD-UK offer guidance on the referral process.